XTANT MEDICAL HOLDINGS, INC. Proceeds from Lines of Credit
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Proceeds from Lines of Credit of $27.89 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2026-08-11
- XTANT MEDICAL HOLDINGS, INC. proceeds from lines of credit for the quarter ending 2026-06-30 was $26.27M, a 1.46% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. proceeds from lines of credit for the quarter ending 2026-03-31 was $1.63M, a 93.52% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. proceeds from lines of credit for the quarter ending 2025-12-31 was $22.49M, a 14.56% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. proceeds from lines of credit for the quarter ending 2025-09-30 was $25.76M, a 3.70% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. proceeds from lines of credit for fiscal 2025 was $100.07M, a 11.16% decline from fiscal 2024.
- XTANT MEDICAL HOLDINGS, INC. proceeds from lines of credit for fiscal 2024 was $112.64M, a 44.01% increase from fiscal 2023.
- XTANT MEDICAL HOLDINGS, INC. proceeds from lines of credit for fiscal 2023 was $78.22M, a 44.24% increase from fiscal 2022.
- XTANT MEDICAL HOLDINGS, INC. proceeds from lines of credit for fiscal 2022 was $54.23M, a 49.14% increase from fiscal 2021.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $26.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $27.89M 10-Q · filed 2026-08-11 | $50.39M derived: sum of 3 quarters · filed 2026-08-11 | $76.15M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $1.63M 10-Q · filed 2026-05-13 | $24.12M derived: sum of 2 quarters · filed 2026-05-13 | $49.88M derived: sum of 3 quarters · filed 2026-05-13 | $76.54M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $22.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $48.25M derived: sum of 2 quarters · filed 2026-03-31 | $74.91M derived: sum of 3 quarters · filed 2026-08-11 | $100.07M 10-K · filed 2026-03-31 |
| 2025-09-30 | $25.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $52.41M derived: sum of 2 quarters · filed 2026-08-11 | $77.57M 10-Q · filed 2025-11-10 | $103.90M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $26.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $51.81M 10-Q · filed 2026-08-11 | $78.14M derived: sum of 3 quarters · filed 2026-08-11 | $104.89M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $25.16M 10-Q · filed 2026-05-13 | $51.48M derived: sum of 2 quarters · filed 2026-05-13 | $78.23M derived: sum of 3 quarters · filed 2026-05-13 | $107.35M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $26.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $53.08M derived: sum of 2 quarters · filed 2026-03-31 | $82.19M derived: sum of 3 quarters · filed 2026-03-31 | $112.64M 10-K · filed 2026-03-31 |
| 2024-09-30 | $26.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $55.87M derived: sum of 2 quarters · filed 2025-11-10 | $86.31M 10-Q · filed 2025-11-10 | $109.19M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $29.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $59.56M 10-Q · filed 2025-08-12 | $82.44M derived: sum of 3 quarters · filed 2025-08-12 | $101.53M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $30.45M 10-Q · filed 2025-05-12 | $53.32M derived: sum of 2 quarters · filed 2025-05-12 | $72.41M derived: sum of 3 quarters · filed 2025-05-12 | $92.17M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $22.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $41.96M derived: sum of 2 quarters · filed 2025-03-06 | $61.72M derived: sum of 3 quarters · filed 2025-03-06 | $78.22M 10-K · filed 2025-03-06 |
| 2023-09-30 | $19.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $38.85M derived: sum of 2 quarters · filed 2024-11-12 | $55.34M 10-Q · filed 2024-11-12 | $72.89M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $19.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $36.26M 10-Q · filed 2024-08-08 | $53.80M derived: sum of 3 quarters · filed 2024-08-08 | $63.92M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $16.50M 10-Q · filed 2024-05-15 | $34.04M derived: sum of 2 quarters · filed 2024-05-15 | $44.16M derived: sum of 3 quarters · filed 2024-05-15 | $58.41M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $17.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $27.66M derived: sum of 2 quarters · filed 2024-04-01 | $41.91M derived: sum of 3 quarters · filed 2024-04-01 | $54.23M 10-K · filed 2024-04-01 |
| 2022-09-30 | $10.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $24.36M derived: sum of 2 quarters · filed 2023-11-14 | $36.68M 10-Q · filed 2023-11-14 | $50.27M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $14.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $26.57M 10-Q · filed 2023-08-01 | $40.16M derived: sum of 3 quarters · filed 2023-08-01 | $53.60M derived: sum of 4 quarters · filed 2023-08-01 |
| 2022-03-31 | $12.32M 10-Q · filed 2023-05-04 | $25.91M derived: sum of 2 quarters · filed 2023-05-04 | $39.35M derived: sum of 3 quarters · filed 2023-05-04 | |
| 2021-12-31 | $13.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $27.03M derived: sum of 2 quarters · filed 2023-03-07 | $36.36M 10-K · filed 2023-03-07 | |
| 2021-09-30 | $13.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $22.77M 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $9.33M 10-Q · filed 2022-08-04 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-21 | $0.00 10-Q · filed 2017-11-21 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-03-30 | |||
| 2016-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $4.77M derived: sum of 2 quarters · filed 2017-11-21 | $10.25M 10-K · filed 2017-03-29 | |
| 2016-09-30 | $2.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-21 | $8.35M 10-Q · filed 2017-11-21 | ||
| 2016-06-30 | $5.48M 10-Q · filed 2018-03-30 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $0.00 10-K · filed 2017-03-29 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-10 | |||
| 2014-12-31 | $4.00M 10-K · filed 2015-03-18 | |||
| 2014-03-31 | $4.00M 10-Q · filed 2015-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |